此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Sacral Erector Spinae Plane Block for Catheter-Related Bladder Discomfort After HoLEP

2026年11月12日 更新者:Kadriye Dıvrak、Ankara Etlik City Hospital

Evaluation of the Effect of Bilateral Sacral Erector Spinae Plane Block on Postoperative Catheter-Related Bladder Discomfort in Patients Undergoing Holmium Laser Enucleation of the Prostate

Catheter-related bladder discomfort (CRBD) is common after holmium laser enucleation of the prostate (HoLEP). This single-center, randomized, controlled, assessor-blinded trial evaluates whether an ultrasound-guided bilateral sacral erector spinae plane (S-ESP) block performed before general anesthesia reduces the incidence of CRBD compared with general anesthesia alone in men aged 50 to 80 years undergoing elective HoLEP. The primary outcome is the incidence of CRBD at 1 hour after surgery.

研究概览

详细说明

Catheter-related bladder discomfort (CRBD) is a common and distressing postoperative symptom complex in male patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP), characterized by a suprapubic burning sensation, an urge to void, and involuntary bladder spasms due to three-way urinary catheterization and continuous bladder irrigation. The sacral erector spinae plane (S-ESP) block is an ultrasound-guided interfascial plane block that targets the S2-S4 sacral nerve roots, which provide both somatic (via the pudendal nerve) and visceral parasympathetic (via pelvic splanchnic nerves) innervation to the lower urinary tract. While current evidence regarding the efficacy of the S-ESP block against a no-block control group in HoLEP surgery is limited, blocking these sacral pathways may effectively modulate afferent bladder stimuli.

A total of 100 male patients aged 50 to 80 years with ASA physical status I-III scheduled for elective HoLEP surgery under general anesthesia will be randomly assigned in a 1:1 ratio to either the S-ESP block group (Group S, n=50) or the standard care control group (Group G, n=50) using computer-generated randomization and sealed opaque envelopes.

Patients in Group S will be placed in the prone position approximately 30 minutes before surgery under standard monitoring. Using a convex ultrasound transducer (GE HealthCare C1-5 probe) in a longitudinal paramedian orientation at the S2 intermediate sacral crest level, a 22G 80-100 mm echogenic block needle will be advanced in-plane in a craniocaudal direction into the fascial plane between the erector spinae aponeurosis and the sacral crest. Following hydrodissection with 1-2 mL normal saline and negative aspiration, 20 mL of 0.25% bupivacaine will be injected on each side (total 40 mL, 100 mg; not exceeding the maximum safe dose of 2 mg/kg). Sensory blockade will be assessed 30 minutes after block completion via pinprick testing over the bilateral S2-S4 dermatomes.

Both groups will receive a standardized general anesthesia protocol: induction with IV fentanyl (1 mcg/kg), propofol (2-2.5 mg/kg), and rocuronium (0.3 mg/kg) to facilitate laryngeal mask airway (LMA) insertion, followed by maintenance with 1 MAC sevoflurane and titrated remifentanil infusion (0.05-0.2 mcg/kg/min). Approximately 30 minutes before the end of surgery, all patients will receive IV paracetamol (1 g) and IV tramadol (100 mg) for multimodal analgesia, followed by routine postoperative IV paracetamol (1 g twice daily).

An independent anesthesiologist blinded to group allocation will assess postoperative outcomes at 30 minutes and at 1, 2, 4, 6, 12, and 24 hours. If the Visual Analog Scale (VAS) pain score is ≥4, IV tramadol (1 mg/kg, up to 400 mg/day) will be administered as rescue analgesia. If the CRBD score is ≥2 after excluding mechanical catheter obstruction, rescue antispasmodic or antimuscarinic medication will be administered. Quality of recovery will be evaluated at 24 hours using the validated Turkish version of the 15-item Quality of Recovery scale (QoR-15T).

研究类型

介入性

注册 (估计的)

100

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Derya Ozkan, Prof., MD
  • 电话号码:00905425843638
  • 邮箱:derya_z@yahoo.com

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

50年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

男性

描述

Inclusion Criteria:

  • Male patients aged between 50 and 80 years
  • American Society of Anesthesiologists (ASA) physical status class I to III
  • Scheduled for elective Holmium Laser Enucleation of the Prostate (HoLEP) surgery under general anesthesia
  • Patients who agree to participate in the study and sign the written informed consent form

Exclusion Criteria:

  • Age under 50 years or over 80 years
  • ASA physical status class IV or higher
  • Known hypersensitivity or allergy to local anesthetics
  • History of chronic opioid use
  • Chronic pain syndrome
  • History of peripheral neuropathy, sacral neurological disease, or neurogenic bladder
  • Overactive bladder or prominent preoperative bladder irritation symptoms
  • History of previous prostate, bladder neck, or lower urinary tract surgery
  • Active urinary tract infection
  • Anticoagulant/antiplatelet use that contraindicates block administration according to current regional anesthesia guidelines, or clinically significant coagulopathy
  • Infection or severe dermatological lesion at the block application site
  • Severe renal failure (eGFR < 30 mL/min/1.73m2) or clinically significant hepatic failure
  • Cognitive impairment, communication difficulty, or psychiatric/neurological condition preventing postoperative assessments
  • Anticipated need for postoperative intensive care unit admission
  • Presence of a preoperative indwelling urinary catheter
  • Emergency surgery
  • Patient refusal or withdrawal of consent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:S-ESPB Group

Ultrasound-guided bilateral sacral erector spinae plane block with 20 mL of 0.25% bupivacaine per side, performed about 30 minutes before surgery, followed by standardized general anesthesia.

Ultrasound-guided bilateral sacral erector spinae plane block with 20 mL of 0.25% bupivacaine per side, performed about 30 minutes before surgery, followed by standardized general anesthesia

有源比较器:Standard Care Group

Standardized general anesthesia without any block or sham injection.

Standardized general anesthesia without any block.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of Catheter-Related Bladder Discomfort (CRBD) at Postoperative 1 Hour
大体时间:1 hour after surgery

CRBD is graded on a 4-point scale: 0 = none; 1 = mild (reported only on questioning); 2 = moderate (reported spontaneously, without behavioral responses); 3 = severe (reported spontaneously with behavioral responses such as strong verbal response, flailing limbs or attempts to remove the catheter). Incidence is the proportion of patients with a score of 1 or higher.

1 hour after surgery

次要结果测量

结果测量
措施说明
大体时间
Incidence of CRBD at other time points
大体时间:30 minutes and 2, 4, 6, 12 and 24 hours after surgery

Proportion of patients with CRBD score of 1 or higher

30 minutes and 2, 4, 6, 12 and 24 hours after surgery
Severity of CRBD
大体时间:30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery

CRBD severity will be graded on a 4-point ordinal scale from 0 (none) to 3 (severe). Moderate-to-severe CRBD is defined as a score ≥2.

30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery
Postoperative pain score
大体时间:30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery

Postoperative pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain).

30 minutes and 1, 2, 4, 6, 12 and 24 hours after surgery
Intraoperative remifentanil consumption
大体时间:Intraoperative period

Total amount of intraoperative remifentanil consumed, recorded in micrograms (mcg) and normalized to body weight and duration (mcg/kg/hour).

Intraoperative period
Total Postoperative Rescue Analgesic Consumption
大体时间:First 24 hours after surgery

Total intravenous tramadol dose in milligrams

First 24 hours after surgery
Time to First Rescue Analgesic Request
大体时间:First 24 hours after surgery

Minutes from end of surgery to first rescue tramadol dose

First 24 hours after surgery
Antispasmodic or antimuscarinic requirement
大体时间:First 24 hours after surgery

Proportion of patients requiring additional antispasmodic or antimuscarinic medication for persistent moderate-to-severe CRBD (score ≥2)

First 24 hours after surgery
Incidence of Postoperative Nausea and Vomiting (PONV) and Other Adverse Events
大体时间:First 24 hours after surgery

Number and percentage of participants experiencing postoperative nausea and vomiting (PONV) or any block- or anesthesia-related adverse events.

First 24 hours after surgery
Postoperative Quality of Recovery Score (QoR-15T)
大体时间:At 24 hours after surgery

Quality of recovery will be evaluated using the validated Turkish version of the 15-item Quality of Recovery scale (QoR-15T). Total scores range from 0 to 150, with higher scores indicating better postoperative recovery quality.

At 24 hours after surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Derya Ozkan, Prof., MD、Ankara Etlik City Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月19日

初级完成 (估计的)

2027年3月16日

研究完成 (估计的)

2027年3月31日

研究注册日期

首次提交

2026年11月12日

首先提交符合 QC 标准的

2026年11月12日

首次发布 (实际的)

2026年11月18日

研究记录更新

最后更新发布 (实际的)

2026年11月18日

上次提交的符合 QC 标准的更新

2026年11月12日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

All personal data will be anonymized and individual participant data will not be made publicly available in accordance with institutional ethics committee approval.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅